Cargando…
Immune gene signatures as prognostic criteria for cancer patients
Recently, the possibility of using immune gene signatures (IGSs) has been considered as a novel prognostic tool for numerous cancer types. State-of-the-art methods of genomic, transcriptomic, and protein analysis have allowed the identification of a number of immune signatures correlated to disease...
Autores principales: | Larionova, Irina, Tashireva, Liubov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399276/ https://www.ncbi.nlm.nih.gov/pubmed/37547445 http://dx.doi.org/10.1177/17588359231189436 |
Ejemplares similares
-
Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials
por: Zhou, Jian-Guo, et al.
Publicado: (2022) -
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer
por: Pernas, Sonia, et al.
Publicado: (2022) -
Clinically relevant fusion oncogenes: detection and practical
implications
por: Sorokin, Maksim, et al.
Publicado: (2022) -
A transcriptomics approach to expand therapeutic options and optimize
clinical trials in oncology
por: Lazar, Vladimir, et al.
Publicado: (2023) -
Identification of a Signature Comprising 5 Soluble Carrier Family Genes to Predict the Recurrence of Papillary Thyroid Carcinoma
por: Han, Rui, et al.
Publicado: (2021)